Nitric oxide reduces both total peripheral resistance and venous return, thus decreasing both
preload and
afterload. So, it can be used in severe
congestive heart failure where this combination of effects can act to increase
cardiac output. In situations where cardiac output is normal, the effect is to reduce
blood pressure.[13][15] It is sometimes also used to induce hypotension (to reduce bleeding) for surgical procedures (for which it is also
FDA,
TGA, and
MHRA labelled).[13][14][16]
The medication is extremely beneficial for use in medical patients because the effects of the medication will directly stop the second that it stops being infused. This is due to the metabolism of the drug, and the rapid inactivation to thiocyanate once conversion of the drug stops.
Sodium nitroprusside should not be used for compensatory hypertension (e.g. due to an arteriovenous stent or coarctation of the aorta).[15] It should not be used in patients with inadequate cerebral circulation or in patients who are near death. It should not be used in patients with
vitamin B12 deficiency, anaemia, severe renal disease, or hypovolaemia.[15] Patients with conditions associated with a higher cyanide/thiocyanate ratio (e.g. congenital (Leber's) optic atrophy, tobacco amblyopia) should only be treated with sodium nitroprusside with great caution.[15] Its use in patients with acute congestive heart failure associated with reduced peripheral resistance is also not recommended.[15] Its use in hepatically impaired individuals is also not recommended, as is its use in cases of pre-existing
hypothyroidism.[13]
Its use in pregnant women is advised against, although the available evidence suggests it may be safe, provided maternal pH and cyanide levels are closely monitored.[15][27] Some evidence suggests sodium nitroprusside use in critically ill children may be safe, even without monitoring of
cyanide level.[28]
Interactions
The only known drug interactions are
pharmacodynamic in nature, that is it is possible for other antihypertensive drugs to reduce the threshold for dangerous hypotensive effects to be seen.[15]
Overdose
Due to its cyanogenic nature, overdose may be particularly dangerous. Treatment of sodium nitroprusside overdose includes the following:[15][29]
Discontinuing sodium nitroprusside administration
Buffering the cyanide by using
sodium nitrite to convert haemoglobin to methaemoglobin as much as the patient can safely tolerate
Haemodialysis is ineffective for removing cyanide from the body but it can be used to remove most of the thiocyanate produced from the above procedure.[15]
Toxicology
The cyanide can be detoxified by reaction with a
sulfur-donor such as
thiosulfate, catalysed by the enzyme
rhodanese.[30] In the absence of sufficient thiosulfate, cyanide ions can quickly reach toxic levels.[30]Hydroxocobalamin can be administered to reduce the risk of thiocyanate toxicity induced by nitroprusside.[31]
As a result of its breakdown to nitric oxide (NO), sodium nitroprusside has potent
vasodilating effects on
arterioles and
venules (arterial more than venous), whereas other nitrates exhibit more selectivity for veins (e.g.
nitroglycerin).[13][15][26][33]
Sodium nitroprusside breaks down in circulation to release
nitric oxide (NO).[8] It does this by binding to oxyhaemoglobin to release cyanide, methaemoglobin and nitric oxide.[8] NO activates
guanylate cyclase in vascular smooth muscle and increases intracellular production of
cGMP. cGMP activates
protein kinase G which activates phosphatases which inactivate myosin light chains.[34]Myosin light chains are involved in smooth muscle contraction. The result is vascular smooth muscle relaxation, which allow vessels to dilate.[34] This mechanism is similar to that of
phosphodiesterase 5 (PDE5) inhibitors such as
sildenafil (Viagra) and
tadalafil (Cialis), which elevate cGMP concentration by inhibiting its degradation by PDE5.[35]
A role for NO in various common psychiatric disorders including
schizophrenia,[36][37][38][39]bipolar disorder[40][41][42] and
major depressive disorder[43][44][45] has been proposed and supported by several clinical findings. These findings may also implicate the potential of drugs that alter NO signalling such as SNP in their treatment.[38][44] Such a role is also supported by the findings of the recent SNP clinical trial.[46]
Structure and properties
Nitroprusside is an
inorganic compound with the
chemical formula Na2[Fe(CN)5NO], usually encountered as the
dihydrate, Na2[Fe(CN)5NO]·2H2O.[47] This red-colored sodium salt dissolves in water or ethanol to give solutions containing the free
complex dianion [Fe(CN)5NO]2−.
Nitroprusside is a complex
anion that features an
octahedral iron(II) centre surrounded by five tightly bound
cyanide ligands and one linear
nitric oxide ligand (Fe-N-O angle = 176.2 °[48]). The anion possesses idealized
C4vsymmetry.
Due to the linear Fe-N-O angle, the relatively short N-O distance of 113 pm[48] and the relatively high stretching frequency of 1947 cm−1, the complex is formulated as containing an NO+ ligand.[49] Consequently, iron is assigned an oxidation state of 2+. The iron center has a diamagnetic
low-spin d6 electron configuration, although a paramagnetic long-lived metastable state has been observed by
EPR spectroscopy.[50]
The chemical reactions of sodium nitroprusside are mainly associated with the NO ligand.[51] For example, addition of
S2− ion to [Fe(CN)5(NO)]2− produces the violet colour [Fe(CN)5(NOS)]4− ion, which is the basis for a sensitive test for S2− ions. An analogous reaction also exists with OH− ions, giving [Fe(CN)5(NO2)]4−.[49]Roussin's red salt (K2[Fe2S2(NO)4]) and
Roussin's black salt (NaFe4S3(NO)7) are related iron nitrosyl complexes. The former was first prepared by treating nitroprusside with sulfur.[52]
Alternatively, the nitrosyl ligand can be introduced using
nitrite:[49]
Other uses
Sodium nitroprusside is often used as a reference compound for the calibration of
Mössbauer spectrometers.[54] Sodium nitroprusside crystals are also of interest for optical storage. For this application, sodium nitroprusside can be reversibly promoted to a metastable excited state by blue-green light, and de-excited by heat or red light.[55]
In physiology research, sodium nitroprusside is frequently used to test endothelium-independent vasodilation.
Iontophoresis, for example, allows local administration of the drug, preventing the systemic effects listed above but still inducing local microvascular vasodilation. Sodium nitroprusside is also used in microbiology, where it has been linked with the dispersal of Pseudomonas aeruginosabiofilms by acting as a nitric oxide donor.[56][57]
Analytical reagent
Sodium nitroprusside is also used as an analytical reagent under the name sodium nitroferricyanide for the detection of methyl
ketones,
amines, and thiols. It is also used as a catalyst in the quantitative determination of ammonia in water samples via the phenate method.[58]
Ketones
The nitroprusside reaction is used for the identification of ketones in urine testing.[59] Sodium nitroprusside was found to give a reaction with acetone or creatine under basic conditions in 1882. Rothera refined this method by the use of ammonia in place of sodium or potassium hydroxide. The reaction was now specific for methyl ketones. Addition of ammonium salts (e.g. ammonium sulfate) improved the sensitivity of the test, too.[60]
In this test, known as Rothera's test, methyl ketones (CH3C(=O)-) under alkaline conditions give bright red coloration (see also
iodoform test). Rothera's test was initially applied to detecting
ketonuria (a symptom of
diabetes) in urine samples. This reaction is now exploited in the form of
urine test strips (e.g. "Ketostix").[61]
Thiols and cysteine
The nitroprusside reaction is a
chemical test used to detect the presence of
thiol groups of
cysteine in proteins. Proteins with the free thiol group give a red colour when added to a solution of sodium nitroprusside in
aqueous ammonia. Some proteins test positive when denatured, indicating that thiol groups are liberated.[62][63][64]
Sodium nitroprusside is used in a separate urinalysis test known as the cyanide nitroprusside test or Brand's test. In this test, sodium cyanide is added first to urine and let stand for about 10 minutes. In this time,
disulfide bonds will be broken by the released cyanide. The destruction of disulfide bonds liberates
cysteine from
cystine as well as
homocysteine from
homocystine. Next, sodium nitroprusside is added to the solution and it reacts with the newly freed
sulfhydryl groups. The test will turn a red/purple colour if the test is positive, indicating significant amounts of amino acids were in the urine (
aminoaciduria). Cysteine, cystine, homocysteine, and homocystine all react when present in the urine when this test is performed. This test can indicate inborn errors of amino acid transporters such as
cystinuria, which results from pathology in the transport of dibasic amino acids.[65]
Amines
Sodium nitroprusside is also used to detect
amines, including those in illicit drugs. This compound is thus used as a stain to indicate amines in
thin layer chromatography.[66] Sodium nitroprusside is similarly used as a presumptive test for the presence of
alkaloids (amine-containing
natural products) common in illicit substances.[67] The test, called
Simon's test, is performed by adding 1 volume of a solution of sodium nitroprusside and
acetaldehyde in
deionized water to a suspected drug, followed by the addition of 2 volumes of an
aqueoussodium carbonate solution. The test turns blue for some
secondary amines. The most common secondary amines encountered in forensic chemistry include 3,4-methylenedioxymethamphetamine (
MDMA, the main component in ecstasy) and
phenethylamines such as
methamphetamine. Sodium nitroprusside is also useful in the identification the
mercaptans (thiol groups) in the nitroprusside reaction.
History
Sodium nitroprusside is primarily used as a vasodilator. It was first used in human medicine in 1928.[8] By 1955, data on its safety during short-term use in people with severe
hypertension had become available.[8] Despite this, due to difficulties in its chemical preparation, it was not finally approved by the
US FDA until 1974 for the treatment of severe hypertension.[8] By 1993, its popularity had grown such that total sales in the US had totalled
US$2 million.[8]
^
abcdefghi"Sodium Nitroprusside". The American Society of Health-System Pharmacists.
Archived from the original on 21 December 2016. Retrieved 8 December 2016.
^World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization.
hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
^World Health Organization (2021). World Health Organization model list of essential medicines: 22nd list (2021). Geneva: World Health Organization.
hdl:10665/345533. WHO/MHP/HPS/EML/2021.02.
^Sirinek KR, Adcock DK, Levine BA (January 1989). "Simultaneous infusion of nitroglycerin and nitroprusside to offset adverse effects of vasopressin during portosystemic shunting". Am. J. Surg.157 (1): 33–37.
doi:
10.1016/0002-9610(89)90416-9.
PMID2491934.
^Yusuf S, Collins R, MacMahon S, Peto R (May 1988). "Effect of intravenous nitrates on mortality in acute myocardial infarction: an overview of the randomised trials". Lancet. 331 (8594): 1088–92.
doi:
10.1016/S0140-6736(88)91906-X.
PMID2896919.
S2CID27098017.
^Knapp E, Gmeiner R (February 1977). "Reduction of pulmonary hypertension by nitroprusside". International Journal of Clinical Pharmacology and Biopharmacy. 15 (2): 75–80.
PMID885667.
^Gałecki P, Maes M, Florkowski A, Lewiński A, Gałecka E, Bieńkiewicz M, Szemraj J (March 2011). "Association between inducible and neuronal nitric oxide synthase polymorphisms and recurrent depressive disorder". Journal of Affective Disorders. 129 (1–3): 175–82.
doi:
10.1016/j.jad.2010.09.005.
PMID20888049.
^
abcHousecroft CE, Sharpe AG (2008). "Chapter 22: d-Block metal chemistry: the first row metals". Inorganic Chemistry (3rd ed.). Pearson. p. 721.
ISBN978-0-13-175553-6.
^Coppens P, Novozhilova I, Kovalevsky A (2002). "Photoinduced Linkage Isomers of Transition-Metal Nitrosyl Compounds and Related Complexes". Chemical Reviews. 102 (4): 861–883.
doi:
10.1021/cr000031c.
PMID11942781.
^Rice EW, Bridgewater L, Easton AD, eds. (2017). Standard Methods for the Examination of Water and Wastewater. American Public Health Association. pp. 4500-NH3 F., 4–114.
ISBN978-0-87553-287-5.
^Finocchiaro R, D'Eufemia P, Celli M, Zaccagnini M, et al. (1998). "Usefulness of cyanide-nitroprusside test in detecting incomplete recessive heterozygotes for cystinuria: a standardized dilution procedure". Journal of Urology and Research. 26 (6): 401–5.
doi:
10.1007/s002400050076.
PMID9879820.
S2CID28323457.